Announcements Trials
Browse Landscape

Phase

Phase 3 1

Status

Completed 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Conditions

Waldenstrom Macroglobulinemia 1Urinary Bladder Neoplasms 1Thrombocythemia, Essential 1Stomach Neoplasms 1Squamous Cell Carcinoma of Head and Neck 1Small Cell Lung Carcinoma 1Salivary Gland Neoplasms 1Recurrence 1Prostatic Neoplasms 1Primary Myelofibrosis 1Precursor T-Cell Lymphoblastic Leukemia-Lymphoma 1Precursor Cell Lymphoblastic Leukemia-Lymphoma 1Precancerous Conditions 1Polycythemia Vera 1Peritoneal Neoplasms 1Neoplasms, Plasma Cell 1Myeloproliferative Disorders 1Myelodysplastic Syndromes 1Multiple Myeloma 1Monoclonal Gammopathy of Undetermined Significance 1Lymphoma, T-Cell, Cutaneous 1Lymphoma, Non-Hodgkin 1Lymphoma, Mantle-Cell 1Lymphoma, Large-Cell, Immunoblastic 1Lymphoma, Large-Cell, Anaplastic 1Lymphoma, Large B-Cell, Diffuse 1Lymphoma, Follicular 1Lymphoma, B-Cell, Marginal Zone 1Lymphoma 1Leukemia, Myeloid, Chronic-Phase 1

Interventions

Psychiatric Rehabilitation 2Methylphenidate 2Vortioxetine 1Vitamin E 1Therapeutics 1Sertraline 1Radiotherapy 1Pharmacogenomic Testing 1Mindfulness 1Ketamine 1Hypericum extract LI 160 1Escitalopram 1Duloxetine Hydrochloride 1Donepezil 1Dehydroepiandrosterone 1Counseling 1Carnitine 1Analgesia 1Acupuncture Therapy 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Phase 3 × Depression × Hypericum extract LI 160 × Clear all
NCT00066859 2021-09-09

Sertraline Compared With Hypericum Perforatum (St.John's Wort) in Treating Depression

Wake Forest University Health Sciences

Phase 3 Completed
2 enrolled

Depression

Data powered by HemOnc (CC BY 4.0) Colophon âš¡